I highlight four American SWAN stocks - Realty Income, Alphabet, Globe Life, and Thermo Fisher Scientific - offering stress-free, blue-chip investment opportunities. Each company boasts strong management, robust balance sheets, consistent earnings, and attractive valuations, trading 18-24% below my fair value estimates. These stocks offer a blended 1.8% yield, low payout ratios, and A or AA credit ratings, supporting reliable dividend growth and low long-term risk.
The Magnificent Seven are often in the spotlight, but not because of any major shifts in their businesses. Some could call it a proverbial flip of the narrative switch to shine the lights on the usual suspects to stir up some fresh buying activity.
NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
![]() GL 6 months ago | Other | $0.24 Per Share |
![]() GL 9 months ago Paid | Quarterly | $0.24 Per Share |
![]() GL 5 Jul 2024 Paid | Quarterly | $0.24 Per Share |
![]() GL 4 Apr 2024 Paid | Quarterly | $0.24 Per Share |
![]() GL 4 Jan 2024 Paid | Quarterly | $0.23 Per Share |
22 Jul 2025 (In 2 weeks) Date | | 3.26 Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | 3.12 Cons. EPS | 3.14 EPS |
23 Oct 2024 Date | | 3.06 Cons. EPS | 3.49 EPS |
24 Jul 2024 Date | | 2.91 Cons. EPS | 2.97 EPS |
![]() GL 6 months ago | Other | $0.24 Per Share |
![]() GL 9 months ago Paid | Quarterly | $0.24 Per Share |
![]() GL 5 Jul 2024 Paid | Quarterly | $0.24 Per Share |
![]() GL 4 Apr 2024 Paid | Quarterly | $0.24 Per Share |
![]() GL 4 Jan 2024 Paid | Quarterly | $0.23 Per Share |
22 Jul 2025 (In 2 weeks) Date | | 3.26 Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | 3.12 Cons. EPS | 3.14 EPS |
23 Oct 2024 Date | | 3.06 Cons. EPS | 3.49 EPS |
24 Jul 2024 Date | | 2.91 Cons. EPS | 2.97 EPS |
Insurance - Life Industry | Financial Services Sector | Frank Martin Svoboda CEO | NYSE Exchange | 37959E102 Cusip |
US Country | 3,732 Employees | - Last Dividend | 2 Jul 2014 Last Split | 30 Dec 1987 IPO Date |
Globe Life Inc. engages in providing a diverse range of life and supplemental health insurance products along with annuities aimed predominantly at lower middle- and middle-income families across the United States. This ambit is structured into four operational segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Initially known as Torchmark Corporation, it underwent a name change to Globe Life Inc. in August 2019, signaling a new era under a brand that reflects its comprehensive offerings in the life insurance market. Founded in 1900, the company has its headquarters located in McKinney, Texas, marking over a century of service in the insurance sector. Globe Life Inc. leverages a variety of channels to market and sell its products, including direct to consumer campaigns, exclusive agencies, and a network of independent agents, ensuring a widespread reach to its target demographic.